Townsend & Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.5M Buy
44,615
+773
+2% +$317K 1.72% 21
2026
Q2
$16.2M Buy
43,842
+1,081
+3% +$457K 1.38% 30
2026
Q1
$20.2M Buy
42,761
+523
+1% +$263K 1.74% 21
2025
Q4
$20.4M Buy
42,238
+483
+1% +$224K 1.82% 19
2025
Q3
$17.8M Buy
41,755
+1,149
+3% +$445K 1.69% 20
2025
Q2
$13.6M Buy
+40,606
New +$14.6M 1.35% 33

Other funds holding HCA

Townsend & Associates's HCA Position: Q3 2026 in Review

Townsend & Associates increased its HCA Healthcare (HCA) stake by 1.8% in Q3 2026, buying an estimated $317K and bringing the position to 44,615 shares worth $20.5M. The position accounts for 1.72% of the portfolio, ranked #21.

Townsend & Associates first reported a position in HCA in Q2 2025 and has held it in 6 quarters since. 489 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Townsend & Associates held 44,615 shares of HCA Healthcare worth $20.5M as of Q3 2026.
  • Townsend & Associates bought 773 HCA Healthcare shares in Q3 2026, an estimated $317K.
  • HCA Healthcare made up 1.72% of Townsend & Associates's portfolio in Q3 2026, its #21 holding.
  • Townsend & Associates first reported a position in HCA Healthcare in Q2 2025 and has held it in 6 quarters since.
  • 489 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Townsend & Associates's 13F filing for Q3 2026, filed 23 Oct 2026.